While platform players are going super-wide in their offering, some legal AI startups are going the other way and drilling ...

Royalty Pharma is less exposed to MFN drug pricing risks, offering downside protection in a volatile policy environment. See ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...

CEO of the National Infusion Center Association argues against a drug price control policy known as “most favored nation.” ...

The MFN EO is designed to halt what the administration calls “global freeloading” — where other developed countries benefit from U.S.-funded drug innovation at significantly lower costs.

By Melanie Whittington President Trump recently signed a new executive order advancing a “most favored nation” (MFN) approach to drug pricing. The policy would link U.S. prices for certain medicines ...

Proposed drug price controls and NIH funding cuts could stall U.S. medical innovation and hinder the development of ...

MFN reinforces the worst incentives in 340B, shifts costs to patients and employers, and threatens the long-term health of both public programs and private enterprise.

President Donald Trump issued an executive order reviving his controversial “Most Favored Nation” (MFN) drug pricing ...

MFN proponents like to frame the policy as a way to stop “foreign freeloading.” But there's nothing tough or strategic about adopting the failed price-fixing systems of Europe or Canada.

I Will Use MFN To Reduce Drug Prices By 30-80%. President Donald Trump, X May 12, 2025. AP.